|
|
Article: Essential Therapeutics Enters Collaborative Agreement With Fujisawa Pharmaceutical Co., Ltd.
- Article from:
- PR Newswire
- Article date:
- August 9, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Essential Therapeutics, Inc., today announced that it has entered into a collaborative agreement with Fujisawa Pharmaceutical Co., Ltd.
Under the agreement, Essential Therapeutics will utilize its technology to develop assay systems for the discovery of novel antibiotics, and will perform high-throughput screening of the compounds in Fujisawa's library through its subcontractor. Fujisawa will conduct lead generation and lead optimization, and will exclusively develop, manufacture and market the resulting products on a worldwide basis. Essential will retain rights to develop the compounds under certain conditions and will receive funding and potential milestone ...